share_log

復星醫藥：海外監管公告 - 第九屆董事會第四十九次會議（定期會議）決議公告

FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Hong Kong Stock Exchange ·  Apr 29 18:30
Summary by Futu AI
上海復星醫藥（集團）股份有限公司（簡稱「復星醫藥」）於2024年4月29日召開第九屆董事會第四十九次會議，全體12名董事出席。會議通過了2024年第一季度報告，並同意向合營公司復星凱特生物科技有限公司提供不超過等值6700萬美元的借款。此次會議由執行董事及董事長吳以芳先生主持，並符合相關法律法規要求。會議決議的借款案需提交股東大會批准，且因董事會成員曾任或現任復星凱特董事，此交易構成關聯交易。相關董事在表決時回避，獨立非執行董事事前已認可此議案。
上海復星醫藥（集團）股份有限公司（簡稱「復星醫藥」）於2024年4月29日召開第九屆董事會第四十九次會議，全體12名董事出席。會議通過了2024年第一季度報告，並同意向合營公司復星凱特生物科技有限公司提供不超過等值6700萬美元的借款。此次會議由執行董事及董事長吳以芳先生主持，並符合相關法律法規要求。會議決議的借款案需提交股東大會批准，且因董事會成員曾任或現任復星凱特董事，此交易構成關聯交易。相關董事在表決時回避，獨立非執行董事事前已認可此議案。
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) HELD ITS 49TH BOARD MEETING ON 29 APRIL 2024, ATTENDED BY ALL 12 DIRECTORS. The Conference approved the 2024 First Quarter Report and agreed to provide a loan of no more than $6700 million equivalent to its joint venture, Fosun Cait Biotechnology Co., Ltd. The meeting was hosted by Mr. Wu Yifang, the Executive Director and Chairman, and complied with relevant legal and regulatory requirements. The Borrowing Bill for the Resolution of the Meeting is subject to approval by the General Meeting and constitutes a related transaction as a member of the Board of Directors is a former or current director of Star Kate. The relevant directors abstained at the time of the vote and the motion was approved before the independent non-executive directors.
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) HELD ITS 49TH BOARD MEETING ON 29 APRIL 2024, ATTENDED BY ALL 12 DIRECTORS. The Conference approved the 2024 First Quarter Report and agreed to provide a loan of no more than $6700 million equivalent to its joint venture, Fosun Cait Biotechnology Co., Ltd. The meeting was hosted by Mr. Wu Yifang, the Executive Director and Chairman, and complied with relevant legal and regulatory requirements. The Borrowing Bill for the Resolution of the Meeting is subject to approval by the General Meeting and constitutes a related transaction as a member of the Board of Directors is a former or current director of Star Kate. The relevant directors abstained at the time of the vote and the motion was approved before the independent non-executive directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.